The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce our 4th annual funding opportunity for gastroesophageal malignancies. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. We support high quality, innovative, and transformative translational and bent research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.
Deadline: October 31st, 2013. Up to $250,000 over two years will be awarded.
Funding Period: January 2014 – December 31, 2015
Amount: $250,000 direct costs for entire grant period (100% of the funding must be dedicated to the research project)
Eligibility: Investigators must be associated with an academic or medical institution possessing a tax-exempt status under section 501 (c) (3) of the IRS code. Research projects must not be funded currently under a separate mechanism.
Research projects are selected through a rigorous review process, and project goals
must align with The DeGregorio Family Foundation’s mission. Criteria for successful grants are impact, likelihood of completion and making a significant contribution to understanding, diagnosis, or treating gastric or esophageal malignancies.
must align with The DeGregorio Family Foundation’s mission. Criteria for successful grants are impact, likelihood of completion and making a significant contribution to understanding, diagnosis, or treating gastric or esophageal malignancies.
No comments:
Post a Comment